The world’s best-selling cancer drug, Genentech Inc.’s Avastin, now carries a warning about increased risk of infertility in premenopausal women.
The Food and Drug Administration said Avastin’s label as of Sept. 30 includes the new warning regarding “ovarian failure.” Data suggest that some women with the potential of bearing children may become infertile as a result of Avastin and should talk to their doctor before starting treatment, the FDA said.
No comments:
Post a Comment